ABEO CIK: 318306

Abeona Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−65.7
FY22:
−43.5
FY23:
−37.0
FY24:
−56.0
FY25:
−76.3
Change from FY21 to FY25
millions USD
FY21:
66.1
FY22:
−24.0
FY23:
0.21
FY24:
−39.2
FY25:
105
Change from FY21 to FY25
millions USD
FY21:
24.9
FY22:
43.2
FY23:
37.1
FY24:
104
FY25:
26.0
millions USD
FY21:
25.3
FY22:
−24.3
FY23:
0.26
FY24:
8.88
FY25:
54.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−69.8
FY22:
−43.6
FY23:
−37.3
FY24:
−58.5
FY25:
−84.3

All amounts in millions USD Data source:SEC EDGAR